logo
ResearchBunny Logo
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design

Chemistry

Leveraging molecular structure and bioactivity with chemical language models for de novo drug design

M. Moret, I. P. Angona, et al.

Dive into cutting-edge drug design with our exploration of hybrid chemical language models, spearheaded by Michael Moret and team. Discover how we crafted a virtual library of novel PI3Kγ ligands, leading to the identification of potent compounds that inhibit cancer cell pathways.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny